These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 3487253

  • 1. Flow-induced release of endothelium-derived relaxing factor.
    Rubanyi GM, Romero JC, Vanhoutte PM.
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1145-9. PubMed ID: 3487253
    [Abstract] [Full Text] [Related]

  • 2. Potassium-induced release of endothelium-derived relaxing factor from canine femoral arteries.
    Rubanyi GM, Vanhoutte PM.
    Circ Res; 1988 Jun; 62(6):1098-103. PubMed ID: 3260148
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM, Vanhoutte PM.
    Blood Vessels; 1988 Jun; 25(2):75-81. PubMed ID: 3257889
    [Abstract] [Full Text] [Related]

  • 4. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.
    Rubanyi GM, Vanhoutte PM.
    Am J Physiol; 1986 May; 250(5 Pt 2):H822-7. PubMed ID: 3010744
    [Abstract] [Full Text] [Related]

  • 5. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
    Rubanyi GM, McKinney M, Vanhoutte PM.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
    [Abstract] [Full Text] [Related]

  • 6. Release of EDRF from canine renal artery by leukotriene D4.
    Pawloski JR, Chapnick BM.
    Am J Physiol; 1990 May; 258(5 Pt 2):H1449-56. PubMed ID: 2159728
    [Abstract] [Full Text] [Related]

  • 7. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA, Stewart DJ, Guérard MJ.
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [Abstract] [Full Text] [Related]

  • 8. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
    Rubanyi GM, Hoeffner U, Schwartz A, Vanhoutte PM.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
    [Abstract] [Full Text] [Related]

  • 9. Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines.
    Rubanyi GM, Lorenz RR, Vanhoutte PM.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H95-101. PubMed ID: 3874557
    [Abstract] [Full Text] [Related]

  • 10. Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor.
    Rubanyi GM, Vanhoutte PM.
    Eur J Pharmacol; 1988 Jan 19; 145(3):351-5. PubMed ID: 3258243
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G.
    J Pharmacol Exp Ther; 1988 Jan 19; 244(1):181-9. PubMed ID: 2826766
    [Abstract] [Full Text] [Related]

  • 12. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy.
    Greenberg SS, Wilcox DE, Rubanyi GM.
    Circ Res; 1990 Dec 19; 67(6):1446-52. PubMed ID: 2173981
    [Abstract] [Full Text] [Related]

  • 13. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow.
    Miller VM, Vanhoutte PM.
    Am J Physiol; 1988 Sep 19; 255(3 Pt 2):H446-51. PubMed ID: 3137826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
    Guo HY, Loren RR, Vanhutte PM.
    Chin Med J (Engl); 1992 Aug 19; 105(8):666-70. PubMed ID: 1458970
    [Abstract] [Full Text] [Related]

  • 18. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G, Iqbal A, Schwartz A, Vanhoutte PM.
    J Pharmacol Exp Ther; 1991 Nov 19; 259(2):639-42. PubMed ID: 1941612
    [Abstract] [Full Text] [Related]

  • 19. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
    Gräser T, Vedernikov YP.
    Biomed Biochim Acta; 1989 Nov 19; 48(4):351-3. PubMed ID: 2787633
    [Abstract] [Full Text] [Related]

  • 20. Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor.
    Förstermann U, Goppelt-Strübe M, Frölich JC, Busse R.
    J Pharmacol Exp Ther; 1986 Jul 19; 238(1):352-9. PubMed ID: 3487639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.